Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results June 29, 2026 Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes June 11, 2026 Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program May 28, 2026 Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference May 12, 2026 Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update May 6, 2026 Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 May 5, 2026 Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026 March 19, 2026 Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update March 12, 2026 Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026 March 9, 2026 Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer March 9, 2026 Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing 123456...»
